Clinical & Educational Resources
Case studies, whitepapers, educational webinars, and more to help support your infection prevention initiatives.
Articles & Documents
Abstract The Use of Chlorhexidine Gluconate Alcohol Hub Disinfection to Prevent CLABSIs
The Use of 3.15% Chlorhexidine Gluconate/70% Alcohol Hub Disinfection to Prevent…
TDB / Compendium Prevantics® Device Swab Clinical Compendium
The Prevantics Device Swab Clinical Compendium provides a complete guide to efficacy data, clinical studies and safety…
TDB / Compendium Prevantics® Skin Antisepsis Clinical Compendium
The Prevantics Skin Antisepsis Clinical Compendium provides a complete guide to efficacy data, clinical studies and…
Video Success Story: Using Prevantics® to reduce CLABSIs
This video is a success story for one facility who implemented Prevantics® Device…
Abstract Sustaining Over Three Years of Zero Central Line-Associated Bloodstream Infections with a Multidisciplinary Team Focus and Phased Interventions
The…
The Use of a 3.15%CHG/70%IPA Disinfection for Sustained CLABSI Reduction in a Large Urban Teaching Facility
The Use of a 3.15%CHG/70%IPA Disinfection for…
Video The Prevantics® Difference: Falling CLABSI Rates & Improved Patient Outcomes
Presented at the 2018 Annual Association for Vascular Access Scientific Meeting.…
Case Study The Prevantics® Difference: Case Studies for Success
Discover how facilities across the U.S. have experienced reduced Central Line Associated Bloodstream Infection…
White Paper Making the Case for Needleless Connector Disinfection with CHG / IPA
Prevention of Intraluminal Contamination of Intravascular Catheters: Making the Case for…
Abstract Reduction in CLABSIs in Oncology Patients
Reduction in Central Line Associated Blood Stream Infections in Oncology Patients. Post-trial of CHG 3.15%70% Alcohol vs Alcohol…
Abstract The Effectiveness of 3.15% CHG / 70% Alcohol Hub Disinfection to Prevent CLABSIs
UNC Rex Healthcare Central line-associated blood stream infection (CLABSI) events…
Video The Prevantics® Difference: Financial Impact + Outcomes
CLABSIs make up 36% of excess cost in US hospitals today. Central line-associated blood stream infections…